About our project
The problem we solve: In response to the ongoing global COVID-19 pandemic, PhenoMx has created the PhenoCHEST (TM) rapid CT screening protocol.
This new tool leverages non-invasive CT scanning, digital chest X-Rays and start-of-the-art Artificial Intelligence algorithms to rapidly score findings and characteristics associated with the presence of COVID-19.
PhenoCHEST (TM) has been developed using a limited real-world data set from patients infected with COVID-19 in both China and South Korea.
About our solution:
Our image processing platform helps screen & triage suspected cases from the time of onset of symptoms to the reporting of results from PCT testing, limiting the exposure and transmission to other people. For example, when a patient develops fever, cough, etc, they can be arrive at an imaging facility, even separate from the hospital, to be scanned and receive a result in under 2 minutes, compared with arriving at a crowded ER/Urgent Care facility with the possibility of infecting or becoming infected via other while waiting for a PCR test, and then waiting days for a result. During the crisis in China they were scanning on average 200 people per day per scanner (approx every 5-7 minutes).
Progress to
date:Dialogue with FDA & FEMA yesterday and the Spanish Government today. Currently involved in a clinical trial in Korea (executed data sharing agreement, IRB submission, protocol, and MOU). In discussions with Germany, India, Italy, Spain, Thailand, UAE, and USA.
About Our Team
Creator: Digital Health
Location: New York
Bio: We Improve Lives, Transforming Medicine Along the Way
Title: PhenoMx
Advanced Degree(s): MD
About Our Company
Innovation Details
Intellectual Property Summary
The PhenoCHEST solution contains proprietary image processing algorithms that have not yet been patented but will remain undisclosed.
Clinical Information
PhenoCHEST is based on clinical images derived from equipment that has been cleared by respective regulatory authorities and government notified bodies. This tool is being provided to healthcare systems and clinicians on an investigational basis.
Regulatory Status
PhenoCHEST is based on clinical images derived from equipment that has been cleared by respective regulatory authorities and government notified bodies. This tool is being provided to healthcare systems and clinicians on an investigational basis. Application for FDA Approval would be under consideration with funds raised.
How we will use the funds raised
Funding and grants obtained through this effort will accelerate our go-to-market strategy and can support ongoing product development and regulatory efforts.
Thank You
We are a team of biomedical engineers and medical doctors with over 20 years of experience managing global multi-center clinical trial specifically for quantitative imaging. Our backgrounds in AI, imaging processing & hardware, healthcare administration, and medical device position us well to contribute to the ongoing battle against the coronavirus pandemic. We are seeking your support to provide PhenoCHEST to healthcare systems around the globe.
